A tumor-associated fibronectin isoform generated by alternative splicing of messenger RNA precursors

doi:10.1083/jcb.108.3.1139

This Article

Full Text (PDF, 4460K)

Alert me when this article is cited

Citation Map

Services

Email this article

Similar articles in this journal

Similar articles in PubMed

Alert me to new content in the JCB

Download to citation manager

Citing Articles

Citing Articles via HighWire

Citing Articles via CrossRef

Citing Articles via Google Scholar

Google Scholar

Articles by Carnemolla, B.

Articles by Natali, P. G.

Search for Related Content

PubMed

PubMed Citation

Articles by Carnemolla, B.

Articles by Natali, P. G.

Pubmed/NCBI databases

Medline Plus Health Information
Substance via MeSH
Cancer

Social Bookmarking

What's this?

ARTICLES

A tumor-associated fibronectin isoform generated by alternative splicing of messenger RNA precursors

B Carnemolla, E Balza, A Siri, L Zardi, MR Nicotra, A Bigotti and PG Natali
Cell Biology Laboratory, Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy.

Fibronectin (FN) represents the mixture of a number of structurally different molecules (isoforms) whose make-up varies depending on the FN sources. FN from cultured transformed human cells has a very different isoform composition with respect to its normal counterpart. In fact, SV- 40-transformed WI-38VAI3 human fibroblasts produce high levels of a FN isoform (B-FN) which is very poorly expressed in their normal, WI-38, counterpart. We have recently demonstrated that the B-FN isoform derives from a differential splicing pattern of the FN primary transcript which leads, in transformed cells, to a high level expression of the exon ED-B (Zardi, L., B. Carnemolla, A. Siri, T. E. Petersen, G. Paolella, G. Sebastio, and F. E. Baralle. 1987. EMBO (Eur. Mol. Biol. Organ.) J. 6:2337-2342). Here we report on the production and characterization of a monoclonal antibody (BC-1) which recognizes an epitope within the protein sequence coded for by the ED-B exon. This monoclonal antibody makes it possible to carry out immunohistochemical analysis of the distribution of the ED-B-containing FN isoform (B-FN) in human tissues. The results show that while in normal, adult, human tissues total FN has a widespread distribution, the B-FN isoform is restricted only to synovial cells, to some vessels and areas of the interstitium of the ovary, and to the myometrium. On the contrary, the B-FN isoform has a much greater expression in fetal and tumor tissues. These results demonstrate that, in vivo, different FN isoforms have a differential distribution and indicate that the B-FN isoform may play a role in ontogenesis and oncogenetic processes.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Ventura, E., Sassi, F., Fossati, S., Parodi, A., Blalock, W., Balza, E., Castellani, P., Borsi, L., Carnemolla, B., Zardi, L. (2009). Use of Uteroglobin for the Engineering of Polyvalent, Polyspecific Fusion Proteins. J. Biol. Chem. 284: 26646-26654 [Abstract] [Full Text]
Sauer, S., Erba, P. A., Petrini, M., Menrad, A., Giovannoni, L., Grana, C., Hirsch, B., Zardi, L., Paganelli, G., Mariani, G., Neri, D., Durkop, H., Menssen, H. D. (2009). Expression of the oncofetal ED-B-containing fibronectin isoform in hematologic tumors enables ED-B-targeted 131I-L19SIP radioimmunotherapy in Hodgkin lymphoma patients. Blood 113: 2265-2274 [Abstract] [Full Text]
Ambesi, A., McKeown-Longo, P. J. (2009). Anastellin, the Angiostatic Fibronectin Peptide, Is a Selective Inhibitor of Lysophospholipid Signaling. Mol Cancer Res 7: 255-265 [Abstract] [Full Text]
Rossin, R., Berndorff, D., Friebe, M., Dinkelborg, L. M., Welch, M. J. (2007). Small-Animal PET of Tumor Angiogenesis Using a 76Br-Labeled Human Recombinant Antibody Fragment to the ED-B Domain of Fibronectin. JNM 48: 1172-1179 [Abstract] [Full Text]
Grabulovski, D., Kaspar, M., Neri, D. (2007). A Novel, Non-immunogenic Fyn SH3-derived Binding Protein with Tumor Vascular Targeting Properties. J. Biol. Chem. 282: 3196-3204 [Abstract] [Full Text]
Berndorff, D., Borkowski, S., Moosmayer, D., Viti, F., Muller-Tiemann, B., Sieger, S., Friebe, M., Hilger, C. S., Zardi, L., Neri, D., Dinkelborg, L. M. (2006). Imaging of Tumor Angiogenesis Using 99mTc-Labeled Human Recombinant Anti-ED-B Fibronectin Antibody Fragments. JNM 47: 1707-1716 [Abstract] [Full Text]
Moosmayer, D., Berndorff, D., Chang, C.-H., Sharkey, R. M., Rother, A., Borkowski, S., Rossi, E. A., McBride, W. J., Cardillo, T. M., Goldenberg, D. M., Dinkelborg, L. M. (2006). Bispecific antibody pretargeting of tumor neovasculature for improved systemic radiotherapy of solid tumors.. Clin. Cancer Res. 12: 5587-5595 [Abstract] [Full Text]
Tijink, B. M., Neri, D., Leemans, C. R., Budde, M., Dinkelborg, L. M., Stigter-van Walsum, M., Zardi, L., van Dongen, G. A.M.S. (2006). Radioimmunotherapy of Head and Neck Cancer Xenografts Using 131I-Labeled Antibody L19-SIP for Selective Targeting of Tumor Vasculature. JNM 47: 1127-1135 [Abstract] [Full Text]
Balza, E., Mortara, L., Sassi, F., Monteghirfo, S., Carnemolla, B., Castellani, P., Neri, D., Accolla, R. S., Zardi, L., Borsi, L. (2006). Targeted Delivery of Tumor Necrosis Factor-{alpha} to Tumor Vessels Induces a Therapeutic T Cell-Mediated Immune Response that Protects the Host Against Syngeneic Tumors of Different Histologic Origin. Clin. Cancer Res. 12: 2575-2582 [Abstract] [Full Text]
Berndorff, D., Borkowski, S., Sieger, S., Rother, A., Friebe, M., Viti, F., Hilger, C. S., Cyr, J. E., Dinkelborg, L. M. (2005). Radioimmunotherapy of Solid Tumors by Targeting Extra Domain B Fibronectin: Identification of the Best-Suited Radioimmunoconjugate. Clin. Cancer Res. 11: 7053s-7063s [Abstract] [Full Text]
Kessler, T., Bieker, R., Padro, T., Schwoppe, C., Persigehl, T., Bremer, C., Kreuter, M., Berdel, W. E., Mesters, R. M. (2005). Inhibition of Tumor Growth by RGD Peptide-Directed Delivery of Truncated Tissue Factor to the Tumor Vasculature. Clin. Cancer Res. 11: 6317-6324 [Abstract] [Full Text]
Carter, P., Smith, L., Ryan, M. (2004). Identification and validation of cell surface antigens for antibody targeting in oncology. Endocr Relat Cancer 11: 659-687 [Abstract] [Full Text]
Borsi, L., Balza, E., Carnemolla, B., Sassi, F., Castellani, P., Berndt, A., Kosmehl, H., Biro, A., Siri, A., Orecchia, P., Grassi, J., Neri, D., Zardi, L. (2003). Selective targeted delivery of TNF{alpha} to tumor blood vessels. Blood 102: 4384-4392 [Abstract] [Full Text]
Filenius, S., Tervo, T., Virtanen, I. (2003). Production of Fibronectin and Tenascin Isoforms and Their Role in the Adhesion of Human Immortalized Corneal Epithelial Cells. IOVS 44: 3317-3325 [Abstract] [Full Text]
Halin, C., Gafner, V., Villani, M. E., Borsi, L., Berndt, A., Kosmehl, H., Zardi, L., Neri, D. (2003). Synergistic Therapeutic Effects of a Tumor Targeting Antibody Fragment, Fused to Interleukin 12 and to Tumor Necrosis Factor {alpha}. Cancer Res. 63: 3202-3210 [Abstract] [Full Text]
Tsunoda, T., Inada, H., Kalembeyi, I., Imanaka-Yoshida, K., Sakakibara, M., Okada, R., Katsuta, K., Sakakura, T., Majima, Y., Yoshida, T. (2003). Involvement of Large Tenascin-C Splice Variants in Breast Cancer Progression. Am. J. Pathol. 162: 1857-1867 [Abstract] [Full Text]
Castellani, P., Borsi, L., Carnemolla, B., Biro, A., Dorcaratto, A., Viale, G. L., Neri, D., Zardi, L. (2002). Differentiation between High- and Low-Grade Astrocytoma Using a Human Recombinant Antibody to the Extra Domain-B of Fibronectin. Am. J. Pathol. 161: 1695-1700 [Abstract] [Full Text]
Fukuda, T., Yoshida, N., Kataoka, Y., Manabe, R.-i., Mizuno-Horikawa, Y., Sato, M., Kuriyama, K., Yasui, N., Sekiguchi, K. (2002). Mice Lacking the EDB Segment of Fibronectin Develop Normally but Exhibit Reduced Cell Growth and Fibronectin Matrix Assembly in Vitro. Cancer Res. 62: 5603-5610 [Abstract] [Full Text]
Carnemolla, B., Borsi, L., Balza, E., Castellani, P., Meazza, R., Berndt, A., Ferrini, S., Kosmehl, H., Neri, D., Zardi, L. (2002). Enhancement of the antitumor properties of interleukin-2 by its targeted delivery to the tumor blood vessel extracellular matrix. Blood 99: 1659-1665 [Abstract] [Full Text]
Filla, M. S., Liu, X., Nguyen, T. D., Polansky, J. R., Brandt, C. R., Kaufman, P. L., Peters, D. M. (2002). In Vitro Localization of TIGR/MYOC in Trabecular Meshwork Extracellular Matrix and Binding to Fibronectin. IOVS 43: 151-161 [Abstract] [Full Text]
Giovannoni, L., Viti, F., Zardi, L., Neri, D. (2001). Isolation of anti-angiogenesis antibodies from a large combinatorial repertoire by colony filter screening. Nucleic Acids Res 29: e27-e27 [Abstract] [Full Text]
Nilsson, F., Kosmehl, H., Zardi, L., Neri, D. (2001). Targeted Delivery of Tissue Factor to the ED-B Domain of Fibronectin, a Marker of Angiogenesis, Mediates the Infarction of Solid Tumors in Mice. Cancer Res. 61: 711-716 [Abstract] [Full Text]
Korhonen, M., Ormio, M., Burgeson, R. E., Virtanen, I., Savilahti, E. (2000). Unaltered Distribution of Laminins, Fibronectin, and Tenascin in Celiac Intestinal Mucosa. J. Histochem. Cytochem. 48: 1011-1020 [Abstract] [Full Text]
Midulla, M., Verma, R., Pignatelli, M., Ritter, M. A., Courtenay-Luck, N. S., George, A. J. T. (2000). Source of Oncofetal ED-B-containing Fibronectin: Implications of Production by Both Tumor and Endothelial Cells. Cancer Res. 60: 164-169 [Abstract] [Full Text]
Claudepierre, P., Allanore, Y., Belec, L., Larget-Piet, B., Zardi, L., Chevalier, X. (1999). Increased Ed-B fibronectin plasma levels in spondyloarthropathies: comparison with rheumatoid arthritis patients and a healthy population. Rheumatology (Oxford) 38: 1099-1103 [Abstract] [Full Text]
Carnemolla, B., Castellani, P., Ponassi, M., Borsi, L., Urbini, S., Nicolo, G., Dorcaratto, A., Viale, G., Winter, G., Neri, D., Zardi, L. (1999). Identification of a Glioblastoma-Associated Tenascin-C Isoform by a High Affinity Recombinant Antibody. Am. J. Pathol. 154: 1345-1352 [Abstract] [Full Text]
Manabe, R.-i., Oh-e, N., Sekiguchi, K. (1999). Alternatively Spliced EDA Segment Regulates Fibronectin-dependent Cell Cycle Progression and Mitogenic Signal Transduction. J. Biol. Chem. 274: 5919-5924 [Abstract] [Full Text]
Liu, C., Yao, J., de Belle, I., Huang, R.-P., Adamson, E., Mercola, D. (1999). The Transcription Factor EGR-1 Suppresses Transformation of Human Fibrosarcoma HT1080 Cells by Coordinated Induction of Transforming Growth Factor-beta 1, Fibronectin, and Plasminogen Activator Inhibitor-1. J. Biol. Chem. 274: 4400-4411 [Abstract] [Full Text]
Kumazaki, T, Mitsui, Y, Hamada, K, Sumida, H, Nishiyama, M (1999). Detection of alternative splicing of fibronectin mRNA in a single cell. J. Cell Sci. 112: 1449-1453 [Abstract]
Viti, F., Tarli, L., Giovannoni, L., Zardi, L., Neri, D. (1999). Increased Binding Affinity and Valence of Recombinant Antibody Fragments Lead to Improved Targeting of Tumoral Angiogenesis. Cancer Res. 59: 347-352 [Abstract] [Full Text]
Serini, G., Bochaton-Piallat, M.-L., Ropraz, P., Geinoz, A., Borsi, L., Zardi, L., Gabbiani, G. (1998). The Fibronectin Domain ED-A Is Crucial for Myofibroblastic Phenotype Induction by Transforming Growth Factor-{beta}1. JCB 142: 873-881 [Abstract] [Full Text]
PAU, A., BRUZZONE, L., DORCARATTO, A., VIALE, G., MARIANI, G., CASTELLANI, P., SIRI, A., ZARDI, L. (1998). Accumulation of oncofetal fibronectin in the vessels of anaplastic meningiomas. J. Neurol. Neurosurg. Psychiatry 64: 412-413 [Full Text]
Shih, I, Wang, T, Wu, T, Kurman, R., Gearhart, J. (1998). Expression of Mel-CAM in implantation site intermediate trophoblastic cell line, IST-1, limits its migration on uterine smooth muscle cells. J. Cell Sci. 111: 2655-2664 [Abstract]
Manabe, R.-i., Oh-e, N., Maeda, T., Fukuda, T., Sekiguchi, K. (1997). Modulation of Cell-adhesive Activity of Fibronectin by the Alternatively Spliced EDA Segment. JCB 139: 295-307 [Abstract] [Full Text]
Slomp, J., Gittenberger-de Groot, A. C., Glukhova, M. A., van Munsteren, J. C., Kockx, M. M., Schwartz, S. M., Koteliansky, V. E. (1997). Differentiation, Dedifferentiation, and Apoptosis of Smooth Muscle Cells During the Development of the Human Ductus Arteriosus. Arterioscler. Thromb. Vasc. Bio. 17: 1003-1009 [Abstract] [Full Text]
Korhonen, M., Virtanen, I. (1997). The Distribution of Laminins and Fibronectins Is Modulated During Extravillous Trophoblastic Cell Differentiation and Decidual Cell Response to Invasion in the Human Placenta. J. Histochem. Cytochem. 45: 569-582 [Abstract] [Full Text]
Huang, X., Molema, G., King, S., Watkins, L., Edgington, T. S., Thorpe, P. E. (1997). Tumor Infarction in Mice by Antibody-Directed Targeting of Tissue Factor to Tumor Vasculature. Science 275: 547-550 [Abstract] [Full Text]
Sasaki, T, Wiedemann, H, Matzner, M, Chu, M., Timpl, R (1996). Expression of fibulin-2 by fibroblasts and deposition with fibronectin into a fibrillar matrix. J. Cell Sci. 109: 2895-2904 [Abstract]
Siri, A., Kn�uper, V., Veirana, N., Caocci, F., Murphy, G., Zardi, L. (1995). Different Susceptibility of Small and Large Human Tenascin-C Isoforms to Degradation by Matrix Metalloproteinases. J. Biol. Chem. 270: 8650-8654 [Abstract] [Full Text]
Lukinmaa, P.-L., Vaheri, A. (1994). ED-A Region-containing Isoform of Cellular Fibronectin is Present in Dentin Matrix in Dentinogenesis Imperfecta Associated with Osteogenesis Imperfecta. JDR 73: 1187-1196 [Abstract]
Damsky, C., Librach, C, Lim, K., Fitzgerald, M., McMaster, M., Janatpour, M, Zhou, Y, Logan, S., Fisher, S. (1994). Integrin switching regulates normal trophoblast invasion. Development 120: 3657-3666 [Abstract]
Mardon, H., Grant, R., Grant, K., Harris, H (1993). Fibronectin splice variants are differentially incorporated into the extracellular matrix of tumorigenic and non-tumorigenic hybrids between normal fibroblasts and sarcoma cells. J. Cell Sci. 104: 783-792 [Abstract]
Mardon, H. J., Sebastio, G. (1992). Regulation of alternative splicing in the IIICS region of human fibronectin pre-mRNA encoding cell binding sites CS1 and CS5. J. Cell Sci. 103: 423-433 [Abstract]
Hynes, R.O., George, E.L., Georges, E.N., Guan, J.-L., Rayburn, H., Yang, J.T. (1992). Toward a Genetic Analysis of Cell-Matrix Adhesion. Cold Spring Harb Symp Quant Biol 57: 249-258 [Abstract]